US Patent 10155820 Anti-endoglin antibodies and uses thereof
Patent 10155820 was granted and assigned to Tracon Pharmaceuticals on December, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 11, 2015
0
Date of Patent
December 18, 2018
0
Patent Applicant
Patent Application Number
15520020
0
Patent Citations Received
Patent Inventor Names
Charles Theuer
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10155820 Anti-endoglin antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
